Trial Profile
Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2021
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary) ; Tobramycin (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Acronyms TOBRAMUC
- 30 Aug 2021 Status changed from recruiting to discontinued due to new treatment that changes the management of the disease.
- 19 Feb 2019 Planned End Date changed from 1 Feb 2021 to 1 Feb 2023.
- 19 Feb 2019 Planned primary completion date changed from 1 Feb 2021 to 1 Feb 2023.